UK Companies House feature
PAJUNK U.K. MEDICAL PRODUCTS LIMITED
Cash
£1M
+35.2% vs 2023
Net assets
£2M
+40.3% vs 2023
Employees
21
+16.7% vs 2023
Profit before tax
£3M
+30.7% vs 2023
Profile
- Company number
- 04112014
- Status
- Active
- Incorporation
- 2000-11-22
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 86101
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | £2,245,832 | £2,935,296 | |
| Net profit | — | — | — | — | £1,786,938 | £2,199,775 | |
| Cash | £871,262 | £321,553 | — | — | £880,140 | £1,189,633 | |
| Total assets less current liabilities | £759,169 | £963,567 | — | — | £1,518,550 | £2,128,170 | |
| Net assets | £758,620 | £963,334 | — | — | £1,514,959 | £2,124,734 | |
| Equity | £758,620 | £963,334 | £972,527 | — | £1,514,959 | £2,124,734 | |
| Average employees | 21 | 16 | — | — | 18 | 21 | |
| Wages | — | — | — | — | £1,542,526 | £1,865,111 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Sumer Auditco Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “We have several new projects and imminent product launches in the pipeline. The launch date for these products is time-sensitive and have been considered in our sales strategy moving forward. If these were to be affected, for one reason or another, this would significantly affect our ability to meet targets set.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BROWN, Stephen | Secretary | 2002-02-15 | — | British |
| BROWN, Stephen | Director | 2002-02-15 | Mar 1963 | British |
| HAUGER, Martin Franz-Josef | Director | 2011-01-01 | Mar 1959 | German |
| PAJUNK-SCHELLING, Simone | Director | 2011-01-01 | Mar 1968 | German |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KAY, Jesamine | Secretary | 2000-11-22 | 2002-02-15 |
| ATHERTON, Robert Michael | Director | 2016-06-01 | 2019-08-14 |
| DUCKWORTH, James Ian | Director | 2000-11-22 | 2002-02-15 |
| KENYON, Douglas Brent | Director | 2002-02-15 | 2012-12-24 |
| TEGG, Stephen Brian | Director | 2016-06-01 | 2019-08-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Pajunk Holding Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-10-28 | Active |
| Mr Stephen Brown | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2024-10-28 |
Filing timeline
Last 20 of 85 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-08 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-01-08 | AD01 | address | change registered office address company with date old address new address |
| 2025-09-17 | AA | accounts | accounts with accounts type full |
| 2025-01-28 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-11-01 | SH08 | capital | capital name of class of shares |
| 2024-10-30 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-10-30 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2024-08-01 | AA | accounts | accounts with accounts type full |
| 2024-01-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-28 | AA | accounts | accounts with accounts type small |
| 2023-01-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-09-30 | AA | accounts | accounts with accounts type small |
| 2022-01-05 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-09-30 | AA | accounts | accounts with accounts type small |
| 2021-01-11 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-10-15 | AA | accounts | accounts with accounts type small |
| 2020-01-03 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2019-09-03 | TM01 | officers | termination director company with name termination date |
| 2019-09-03 | TM01 | officers | termination director company with name termination date |
| 2019-07-15 | AA | accounts | accounts with accounts type small |
Credit score
Altman Z″ (private-firm) · reference 2024-12-31
5.40
SAFE
Altman Z″
- Working capital / Total assets 0.309 × 6.56 = +2.02
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.431 × 6.72 = +2.89
- Book equity / Total liabilities 0.455 × 1.05 = +0.48
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory